Answers are grounded in this paper and cite their sources.
Although fecal immunochemical tests (FITs) have been used for colorectal cancer (CRC) screening in several countries for years, this has not been the case in the United States. The reasons for this are multifactorial, but if the United States hopes to increase screening rates, the evidence is in regarding FIT's benefits and potential. A publication in this issue of the American Journal of Gastroenterology provides "gold standard" evidence of its superiority over the standard guaiac test and opens opportunities for investigators to discover the most effective uses of this test for population screening.
No takes yet. Share an insight, caveat, or question.
James E. Allison (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: